IRIS
Pizzato, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.409
AS - Asia 1.637
EU - Europa 1.276
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 49
OC - Oceania 2
Totale 8.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.271
SG - Singapore 684
IT - Italia 375
CN - Cina 322
VN - Vietnam 306
BR - Brasile 268
RU - Federazione Russa 189
UA - Ucraina 100
FI - Finlandia 97
DE - Germania 88
FR - Francia 86
GB - Regno Unito 81
CA - Canada 76
LV - Lettonia 61
SE - Svezia 61
IN - India 54
HK - Hong Kong 51
KR - Corea 41
NL - Olanda 33
ID - Indonesia 30
AR - Argentina 25
BD - Bangladesh 25
TR - Turchia 24
PL - Polonia 21
AT - Austria 18
MX - Messico 18
IQ - Iraq 17
JP - Giappone 15
EC - Ecuador 14
ZA - Sudafrica 12
CR - Costa Rica 11
ES - Italia 11
LT - Lituania 10
VE - Venezuela 9
JO - Giordania 8
CL - Cile 7
IL - Israele 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
HN - Honduras 6
JM - Giamaica 6
PK - Pakistan 6
UZ - Uzbekistan 6
CO - Colombia 5
DZ - Algeria 5
LB - Libano 5
NI - Nicaragua 5
EG - Egitto 4
HR - Croazia 4
HU - Ungheria 4
IE - Irlanda 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
CW - ???statistics.table.value.countryCode.CW??? 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
MA - Marocco 3
PY - Paraguay 3
SV - El Salvador 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AU - Australia 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
IR - Iran 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GP - Guadalupe 1
KG - Kirghizistan 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
Totale 8.705
Salva come PNG Salva come JPEG
Città #
Ashburn 630
Fairfield 508
Singapore 443
San Jose 292
Chandler 281
Woodbridge 249
Seattle 230
Jacksonville 222
Wilmington 193
Cambridge 176
Houston 168
Council Bluffs 158
Columbus 151
Santa Clara 147
Dallas 140
Ann Arbor 108
Trento 92
Moscow 87
Los Angeles 85
Princeton 84
Ho Chi Minh City 83
San Mateo 81
New York 68
Beijing 67
Hanoi 66
Riga 61
The Dalles 55
Lauterbourg 54
Helsinki 47
Phoenix 47
Hong Kong 38
Munich 38
Boardman 37
Seoul 36
Orem 31
Milan 29
Chicago 28
Rome 27
Como 26
San Diego 26
São Paulo 26
London 24
Mesa 24
Da Nang 21
Jakarta 21
Dearborn 20
Buffalo 19
Chennai 18
Montreal 18
Brooklyn 16
Hefei 16
Warsaw 16
Redondo Beach 15
Tokyo 14
Frankfurt am Main 13
Dong Ket 12
North Bergen 12
Haiphong 11
Johannesburg 11
Vienna 11
St Louis 10
Turin 10
Verona 10
Lappeenranta 9
Mexico City 9
Mumbai 9
San Paolo di Civitate 9
Amsterdam 8
Atlanta 8
Falkenstein 8
Guangzhou 8
Poplar 8
Toronto 8
Elk Grove Village 7
Hillsboro 7
Izmir 7
Miami 7
Nuremberg 7
Turku 7
Washington 7
Brasília 6
Denver 6
Fort Worth 6
Jinan 6
Quito 6
Rio de Janeiro 6
San Francisco 6
San José 6
Shanghai 6
Sofia 6
Stockholm 6
Tashkent 6
Vilnius 6
Belo Horizonte 5
Biên Hòa 5
Bremen 5
Dhaka 5
Düsseldorf 5
Fremont 5
Las Vegas 5
Totale 6.003
Salva come PNG Salva come JPEG
Nome #
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 251
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation 234
SARS-CoV-2 and the Host Cell: A Tale of Interactions 230
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors 228
SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus 225
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins 213
Galanin pathogenic mutations in temporal lobe epilepsy 208
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 198
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists 196
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 194
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26 192
Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior 190
Retroviral factors promoting infectivity. 188
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild 186
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 180
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. 178
The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor 178
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles 174
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents 172
Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK. 168
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity 166
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration 164
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. 160
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 156
Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope 150
Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. 149
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. 146
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. 146
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. 146
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. 144
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. 143
Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. 143
Progress with retroviral gene vectors. 141
Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. 135
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. 134
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. 132
Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. 132
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. 131
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. 130
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. 129
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. 129
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. 125
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 123
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation 120
Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5 120
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. 118
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. 115
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 115
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. 113
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 110
The activity of Nef on HIV-1 infectivity. 104
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. 95
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample 90
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals 89
Retrovirus vectors. 86
The impact of infection risk communication format on tourism travel intentions during COVID-19 86
Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol 85
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity 70
A Two-Step Ion-Exchange Process for Modified Mechanical Reinforcement and Virucidal Functionalization of Glasses 59
Ten questions concerning dynamic sensory variation in salutogenic building design 58
Totale 8.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 568
Totale 36.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022399 0 0 0 0 12 31 7 106 48 49 59 87
2022/2023607 63 68 6 69 52 87 9 54 113 35 31 20
2023/2024332 20 20 18 20 34 84 21 22 5 13 12 63
2024/20251.332 17 11 75 247 79 166 115 82 137 234 76 93
2025/20262.864 184 82 330 476 362 186 519 81 214 268 86 76
2026/20271.042 49 167 276 525 25 0 0 0 0 0 0 0
Totale 8.870